Friday, October 23, 2020

Global pharma firm Indivior pays $600 million to settle U.S. opioid marketing claims

-

Indivior Plc has agreed to pay $600 million and have a subsidiary plead guilty to a felony charge to resolve U.S. allegations that it engaged in an illegal scheme to boost prescriptions of its opioid addiction treatment Suboxone.

The U.S. Justice Department announced the agreement on Friday after the subsidiary, Indivior Solutions Inc, pleaded guilty in Abingdon, Virginia, to making false statements related to healthcare matters.

The agreement came after the parent company was indicted in April 2019 in one of the few corporate prosecutions related to the U.S. opioid addiction epidemic.

The indictment alleged Indivior deceived doctors and healthcare benefit programs into believing the firm’s version of Suboxone, which has an opioid component, was safer and less susceptible to abuse than similar drugs.

- Advertisement -

The indictment said Indivior also used an internet and telephone program touted as a resource for opioid addicts to connect them to doctors it knew were prescribing Suboxone and other opioids at high rates and in suspect circumstances.

Prosecutors said the scheme began before British consumer goods company Reckitt Benckiser spun off Indivior. Reckitt Benckiser last year agreed to pay $1.4 billion to resolved related claims.

In its guilty plea, Indivior Solutions admitted to part of the scheme, that it sent misleading safety information about the drug to Massachusetts’ Medicaid program, the department said.

Indivior’s former chief executive, Shaun Thaxter, pleaded guilty last month to a related misdemeanor charge.

- Advertisement -

Indivior as part of Friday’s deal agreed to disband its Suboxone sales force and remove medical providers from its promotional programs who pose a high risk of inappropriate prescribing.

The company is also settling related civil lawsuits the Justice Department joined in 2018. It will pay $10 million to resolve claims by the Federal Trade Commission that it impeded competition from generic equivalents of Suboxone.

Original article Reuters.com

MUST READ

Goldman Sachs agrees $3 billion settlement with US DoJ over 1MDB corruption scandal

Goldman Sachs has agreed to pay nearly $3bn (£2.3bn) in the US to end a probe of its role in Malaysia's 1MDB corruption scandal. The...

Hong Kong fines Goldman Sachs $350 million over 1MDB scandal

Goldman Sachs ignored multiple red flags over the multibillion-dollar fundraisings it arranged for state fund 1Malaysia Development Berhad, Hong Kong’s financial regulator said on...

Texas attorney general Ken Paxton fires top aide who accused him of bribery

Lacey Mase, one of the top aides who accused Texas Attorney General Ken Paxton of crimes including bribery and abuse of office, has been fired, she told The...

Fundraiser Elliott Broidy pleads guilty in foreign agent case linked to 1MDB

Major Republican Party and Trump fundraiser Elliott Broidy pleaded guilty Tuesday to acting as an unregistered foreign agent, admitting to accepting millions...

Germany issues international arrest warrant for founders of law firm at the centre of Panama Papers

Germany has issued international arrest warrants for the two founders of the firm at the centre of the tax haven scandal exposed by the...
Advertisement
Advertisement

Latest News

This Week

Trial of bitcoin launderer Alexander Vinnik begins in Paris

The trial of a Russian man alleged to have used ransomware in a 135 million euros ($157 million) bitcoin fraud will begin Monday. Alexander Vinnik, who...

Germany issues international arrest warrant for founders of law firm at the centre of Panama Papers

Germany has issued international arrest warrants for the two founders of the firm at the centre of the tax haven scandal exposed by the...

Goldman to pay over $2 billion in DOJ’s 1MDB Probe

Goldman Sachs Group Inc. has reached a long-awaited pact with the U.S. Department of Justice to pay more than $2 billion for the bank’s...

US financial watchdog fines bitcoin mixer operator $60m for money laundering

The founder and operator of some of the first "mixing" services in crypto will have to cough up $60 million to United States regulators,...
Advertisement

Adblock Detected!

Our website is made possible by displaying online advertisements to our visitors. Please consider supporting us by whitelisting our website.

Enable Notifications    Ok No thanks